Melanoma vaccine trial shows promising results
A personalised vaccine has been found to nearly halve the rate of recurrence and death from melanoma.
Researchers say sun-smart prevention is still the best way to avoid skin cancer, but the new treatment could drastically improve outcomes for those who’ve already been diagnosed.
Melanoma Institute Australia co-medical director Prof Richard Scolyer joined Luke Grant to talk about the promising results from the research.
Press PLAY to hear the full interview
Photo: Getty
